ANNALS OF THE RHEUMATIC DISEASES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566406, encodeId=26d256640659, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1333, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530183, encodeId=c0755301830a, content=Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1709, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=609a1613289, createdName=smate19, createdTime=Sat Dec 03 22:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533224, encodeId=50c15332244d, content=你的文章接下来是什么状态呢？smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1467, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oftj3pVzOKDsU7bs1eybib4yD0N5teqtpI8MMoMG4C2CTH3yAhrUBWKG9ibGibSsMaeprbkUkplQcttSlngaJqiahw/132, createdBy=40a21974501, createdName=王豆豆vera, createdTime=Thu Feb 23 08:00:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801995, encodeId=ef3a801995b4, content=审稿速度:1.0 偏重的研究方向：免疫 经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00182486065, createdName=1246b310m74暂无昵称, createdTime=Fri Jul 10 06:56:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052475, encodeId=6afb10524e592, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46af5610127, createdName=ms2000000930681105, createdTime=Sat Sep 18 04:17:05 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917530, encodeId=480691e530c0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：中过两篇通讯文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5e31930205, createdName=千与千寻必中！, createdTime=Sun Jan 17 18:55:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587097, encodeId=773d58e097fe, content=请问这个杂志接收综述吗？审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580561, encodeId=89a1580561c3, content=大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表: 请教各位大神，case report这个杂志收吗？, beContent=150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578735, encodeId=62955e87350c, content=不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2013-01-20 JamesHuang

审稿速度:1.0 | 投稿命中率:25.0
经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......

516 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566406, encodeId=26d256640659, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1333, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530183, encodeId=c0755301830a, content=Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1709, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=609a1613289, createdName=smate19, createdTime=Sat Dec 03 22:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533224, encodeId=50c15332244d, content=你的文章接下来是什么状态呢？smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1467, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oftj3pVzOKDsU7bs1eybib4yD0N5teqtpI8MMoMG4C2CTH3yAhrUBWKG9ibGibSsMaeprbkUkplQcttSlngaJqiahw/132, createdBy=40a21974501, createdName=王豆豆vera, createdTime=Thu Feb 23 08:00:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801995, encodeId=ef3a801995b4, content=审稿速度:1.0 偏重的研究方向：免疫 经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00182486065, createdName=1246b310m74暂无昵称, createdTime=Fri Jul 10 06:56:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052475, encodeId=6afb10524e592, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46af5610127, createdName=ms2000000930681105, createdTime=Sat Sep 18 04:17:05 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917530, encodeId=480691e530c0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：中过两篇通讯文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5e31930205, createdName=千与千寻必中！, createdTime=Sun Jan 17 18:55:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587097, encodeId=773d58e097fe, content=请问这个杂志接收综述吗？审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580561, encodeId=89a1580561c3, content=大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表: 请教各位大神，case report这个杂志收吗？, beContent=150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578735, encodeId=62955e87350c, content=不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-02-01 花开的好香

目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。

1333 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566406, encodeId=26d256640659, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1333, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530183, encodeId=c0755301830a, content=Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1709, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=609a1613289, createdName=smate19, createdTime=Sat Dec 03 22:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533224, encodeId=50c15332244d, content=你的文章接下来是什么状态呢？smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1467, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oftj3pVzOKDsU7bs1eybib4yD0N5teqtpI8MMoMG4C2CTH3yAhrUBWKG9ibGibSsMaeprbkUkplQcttSlngaJqiahw/132, createdBy=40a21974501, createdName=王豆豆vera, createdTime=Thu Feb 23 08:00:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801995, encodeId=ef3a801995b4, content=审稿速度:1.0 偏重的研究方向：免疫 经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00182486065, createdName=1246b310m74暂无昵称, createdTime=Fri Jul 10 06:56:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052475, encodeId=6afb10524e592, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46af5610127, createdName=ms2000000930681105, createdTime=Sat Sep 18 04:17:05 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917530, encodeId=480691e530c0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：中过两篇通讯文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5e31930205, createdName=千与千寻必中！, createdTime=Sun Jan 17 18:55:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587097, encodeId=773d58e097fe, content=请问这个杂志接收综述吗？审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580561, encodeId=89a1580561c3, content=大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表: 请教各位大神，case report这个杂志收吗？, beContent=150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578735, encodeId=62955e87350c, content=不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2016-12-03 smate19

Awaiting AE Assignment
Awaiting Second Opinion Comments
刚出现第二条，是不是直接被拒前都会经历这个状态？

1709 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566406, encodeId=26d256640659, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1333, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530183, encodeId=c0755301830a, content=Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1709, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=609a1613289, createdName=smate19, createdTime=Sat Dec 03 22:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533224, encodeId=50c15332244d, content=你的文章接下来是什么状态呢？smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1467, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oftj3pVzOKDsU7bs1eybib4yD0N5teqtpI8MMoMG4C2CTH3yAhrUBWKG9ibGibSsMaeprbkUkplQcttSlngaJqiahw/132, createdBy=40a21974501, createdName=王豆豆vera, createdTime=Thu Feb 23 08:00:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801995, encodeId=ef3a801995b4, content=审稿速度:1.0 偏重的研究方向：免疫 经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00182486065, createdName=1246b310m74暂无昵称, createdTime=Fri Jul 10 06:56:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052475, encodeId=6afb10524e592, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46af5610127, createdName=ms2000000930681105, createdTime=Sat Sep 18 04:17:05 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917530, encodeId=480691e530c0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：中过两篇通讯文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5e31930205, createdName=千与千寻必中！, createdTime=Sun Jan 17 18:55:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587097, encodeId=773d58e097fe, content=请问这个杂志接收综述吗？审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580561, encodeId=89a1580561c3, content=大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表: 请教各位大神，case report这个杂志收吗？, beContent=150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578735, encodeId=62955e87350c, content=不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2017-02-23 王豆豆vera

你的文章接下来是什么状态呢？smate19 2016-12-03 发表::
Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？

smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？

1467 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566406, encodeId=26d256640659, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1333, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530183, encodeId=c0755301830a, content=Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1709, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=609a1613289, createdName=smate19, createdTime=Sat Dec 03 22:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533224, encodeId=50c15332244d, content=你的文章接下来是什么状态呢？smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1467, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oftj3pVzOKDsU7bs1eybib4yD0N5teqtpI8MMoMG4C2CTH3yAhrUBWKG9ibGibSsMaeprbkUkplQcttSlngaJqiahw/132, createdBy=40a21974501, createdName=王豆豆vera, createdTime=Thu Feb 23 08:00:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801995, encodeId=ef3a801995b4, content=审稿速度:1.0 偏重的研究方向：免疫 经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00182486065, createdName=1246b310m74暂无昵称, createdTime=Fri Jul 10 06:56:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052475, encodeId=6afb10524e592, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46af5610127, createdName=ms2000000930681105, createdTime=Sat Sep 18 04:17:05 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917530, encodeId=480691e530c0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：中过两篇通讯文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5e31930205, createdName=千与千寻必中！, createdTime=Sun Jan 17 18:55:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587097, encodeId=773d58e097fe, content=请问这个杂志接收综述吗？审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580561, encodeId=89a1580561c3, content=大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表: 请教各位大神，case report这个杂志收吗？, beContent=150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578735, encodeId=62955e87350c, content=不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-07-10 1246b310m74暂无昵称

审稿速度:1.0
偏重的研究方向：免疫
经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快

1356 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566406, encodeId=26d256640659, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1333, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530183, encodeId=c0755301830a, content=Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1709, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=609a1613289, createdName=smate19, createdTime=Sat Dec 03 22:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533224, encodeId=50c15332244d, content=你的文章接下来是什么状态呢？smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1467, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oftj3pVzOKDsU7bs1eybib4yD0N5teqtpI8MMoMG4C2CTH3yAhrUBWKG9ibGibSsMaeprbkUkplQcttSlngaJqiahw/132, createdBy=40a21974501, createdName=王豆豆vera, createdTime=Thu Feb 23 08:00:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801995, encodeId=ef3a801995b4, content=审稿速度:1.0 偏重的研究方向：免疫 经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00182486065, createdName=1246b310m74暂无昵称, createdTime=Fri Jul 10 06:56:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052475, encodeId=6afb10524e592, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46af5610127, createdName=ms2000000930681105, createdTime=Sat Sep 18 04:17:05 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917530, encodeId=480691e530c0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：中过两篇通讯文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5e31930205, createdName=千与千寻必中！, createdTime=Sun Jan 17 18:55:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587097, encodeId=773d58e097fe, content=请问这个杂志接收综述吗？审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580561, encodeId=89a1580561c3, content=大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表: 请教各位大神，case report这个杂志收吗？, beContent=150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578735, encodeId=62955e87350c, content=不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-09-18 ms2000000930681105

审稿速度:1.0 | 投稿命中率:5.0
经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！

1018 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566406, encodeId=26d256640659, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1333, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530183, encodeId=c0755301830a, content=Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1709, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=609a1613289, createdName=smate19, createdTime=Sat Dec 03 22:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533224, encodeId=50c15332244d, content=你的文章接下来是什么状态呢？smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1467, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oftj3pVzOKDsU7bs1eybib4yD0N5teqtpI8MMoMG4C2CTH3yAhrUBWKG9ibGibSsMaeprbkUkplQcttSlngaJqiahw/132, createdBy=40a21974501, createdName=王豆豆vera, createdTime=Thu Feb 23 08:00:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801995, encodeId=ef3a801995b4, content=审稿速度:1.0 偏重的研究方向：免疫 经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00182486065, createdName=1246b310m74暂无昵称, createdTime=Fri Jul 10 06:56:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052475, encodeId=6afb10524e592, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46af5610127, createdName=ms2000000930681105, createdTime=Sat Sep 18 04:17:05 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917530, encodeId=480691e530c0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：中过两篇通讯文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5e31930205, createdName=千与千寻必中！, createdTime=Sun Jan 17 18:55:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587097, encodeId=773d58e097fe, content=请问这个杂志接收综述吗？审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580561, encodeId=89a1580561c3, content=大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表: 请教各位大神，case report这个杂志收吗？, beContent=150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578735, encodeId=62955e87350c, content=不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-01-17 千与千寻必中！

审稿速度:1.0 | 投稿命中率:95.0
经验分享：中过两篇通讯文章

1247 0

[GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566406, encodeId=26d256640659, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1333, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530183, encodeId=c0755301830a, content=Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1709, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=609a1613289, createdName=smate19, createdTime=Sat Dec 03 22:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533224, encodeId=50c15332244d, content=你的文章接下来是什么状态呢？smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1467, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oftj3pVzOKDsU7bs1eybib4yD0N5teqtpI8MMoMG4C2CTH3yAhrUBWKG9ibGibSsMaeprbkUkplQcttSlngaJqiahw/132, createdBy=40a21974501, createdName=王豆豆vera, createdTime=Thu Feb 23 08:00:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801995, encodeId=ef3a801995b4, content=审稿速度:1.0 偏重的研究方向：免疫 经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00182486065, createdName=1246b310m74暂无昵称, createdTime=Fri Jul 10 06:56:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052475, encodeId=6afb10524e592, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46af5610127, createdName=ms2000000930681105, createdTime=Sat Sep 18 04:17:05 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917530, encodeId=480691e530c0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：中过两篇通讯文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5e31930205, createdName=千与千寻必中！, createdTime=Sun Jan 17 18:55:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587097, encodeId=773d58e097fe, content=请问这个杂志接收综述吗？审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580561, encodeId=89a1580561c3, content=大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表: 请教各位大神，case report这个杂志收吗？, beContent=150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578735, encodeId=62955e87350c, content=不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-03-21 Michael scofield123

请问这个杂志接收综述吗？审稿速度如何？

1386 0

[GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566406, encodeId=26d256640659, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1333, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530183, encodeId=c0755301830a, content=Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1709, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=609a1613289, createdName=smate19, createdTime=Sat Dec 03 22:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533224, encodeId=50c15332244d, content=你的文章接下来是什么状态呢？smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1467, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oftj3pVzOKDsU7bs1eybib4yD0N5teqtpI8MMoMG4C2CTH3yAhrUBWKG9ibGibSsMaeprbkUkplQcttSlngaJqiahw/132, createdBy=40a21974501, createdName=王豆豆vera, createdTime=Thu Feb 23 08:00:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801995, encodeId=ef3a801995b4, content=审稿速度:1.0 偏重的研究方向：免疫 经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00182486065, createdName=1246b310m74暂无昵称, createdTime=Fri Jul 10 06:56:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052475, encodeId=6afb10524e592, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46af5610127, createdName=ms2000000930681105, createdTime=Sat Sep 18 04:17:05 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917530, encodeId=480691e530c0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：中过两篇通讯文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5e31930205, createdName=千与千寻必中！, createdTime=Sun Jan 17 18:55:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587097, encodeId=773d58e097fe, content=请问这个杂志接收综述吗？审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580561, encodeId=89a1580561c3, content=大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表: 请教各位大神，case report这个杂志收吗？, beContent=150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578735, encodeId=62955e87350c, content=不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-11-27 12536e50m64暂无昵称

大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表::
请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表:
请教各位大神，case report这个杂志收吗？

150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？

1156 0

[GetPortalCommentsPageByObjectIdResponse(id=493551, encodeId=cbb9493551ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2013年1月4号投了一篇关于骨关节炎的文章，3天后显示awaiting AE assignment，1月14号显示等待第二审稿人的答复，1月18第二审稿人答应审稿，目前处于peer review in progress！期待好结果......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9276568, createdName=JamesHuang, createdTime=Sun Jan 20 17:22:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566406, encodeId=26d256640659, content=目前投稿过三篇，前两篇没送外审，3天左右reject，第三篇4天送外审，刚好一个月，三位审稿人，建议大修，现在重新上传，新的一年，希望能有好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1333, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08fb1710649, createdName=花开的好香, createdTime=Fri Feb 01 18:03:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530183, encodeId=c0755301830a, content=Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1709, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=609a1613289, createdName=smate19, createdTime=Sat Dec 03 22:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533224, encodeId=50c15332244d, content=你的文章接下来是什么状态呢？smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , beContent=smate19 2016-12-03 发表:: Awaiting AE Assignment Awaiting Second Opinion Comments 刚出现第二条，是不是直接被拒前都会经历这个状态？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1467, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oftj3pVzOKDsU7bs1eybib4yD0N5teqtpI8MMoMG4C2CTH3yAhrUBWKG9ibGibSsMaeprbkUkplQcttSlngaJqiahw/132, createdBy=40a21974501, createdName=王豆豆vera, createdTime=Thu Feb 23 08:00:00 CST 2017, time=2017-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801995, encodeId=ef3a801995b4, content=审稿速度:1.0 偏重的研究方向：免疫 经验分享：投了一篇通讯，一周内答复，接收，无需修改，等待proof，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1356, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00182486065, createdName=1246b310m74暂无昵称, createdTime=Fri Jul 10 06:56:53 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052475, encodeId=6afb10524e592, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一天上午十点多交稿，第二天上午九点就收到拒信，desk reject。这是我第一次投sci，真的不要太爽！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46af5610127, createdName=ms2000000930681105, createdTime=Sat Sep 18 04:17:05 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917530, encodeId=480691e530c0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：中过两篇通讯文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5e31930205, createdName=千与千寻必中！, createdTime=Sun Jan 17 18:55:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587097, encodeId=773d58e097fe, content=请问这个杂志接收综述吗？审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580561, encodeId=89a1580561c3, content=大神，请问您投了吗？150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？150****7505(暂无匿称) 2018-01-22 11:46:00 发表: 请教各位大神，case report这个杂志收吗？, beContent=150****7505(暂无匿称) 2018-01-22 发表:: 请教各位大神，case report这个杂志收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578735, encodeId=62955e87350c, content=不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

不知道

1335 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务